Ulthera (Merz) Ulthera System (Ultherapy)

Name: Ulthera (Merz) Ulthera System (Ultherapy)
Brand: Ulthera (Merz)

HIFU/Ultrasound Lifting · Microfocused ultrasound + DeepSEE imaging

Work at Ulthera (Merz)? — one claim covers all 1 of your devices.

Legacy-used-marketFDA status under verificationBe the first to review

The Ulthera (Merz) Ulthera System (Ultherapy) typically sells new in the $130k–$175k range in the US, with used and refurbished systems around $20k–$60k. Ulthera (Merz) Ulthera System (Ultherapy)'s FDA status is under verification by our research team. Figures are market estimates verified August 6, 2026.

Last verified: August 6, 2026 · How we verify

New: $130k–$175k|Used: $20k–$60kmarket estimate, no email required

Key facts
Manufacturer	Ulthera (Merz)
Company	Owner: Merz Group (Merz Holding GmbH & Co. KG), founding Merz family (family / founder owned, since 1908) · Distribution: direct
Category	RF Microneedling, Tightening & HIFU
Technology	Microfocused ultrasound + DeepSEE imaging
FDA status	FDA status under verification
New price range	$130k–$175k
Used price range	$20k–$60k
Consumables	Not published
Launch year	2009
Last verified	August 6, 2026

Save device

Bottom line

Ultherapy is still the brand-name king of non-surgical lifting, and a used legacy Ulthera system at $15k-45k looks like the bargain of the used market — until you understand the machine is worthless without Merz-supplied transducers, and Merz controls exactly who gets them. Transducers are serialized, chip-locked consumables sold only to accounts Merz recognizes — a gray-market system you can't register is a paperweight. If you can establish a legitimate Merz account (verify in writing before wiring money), legacy Ultherapy remains highly profitable; otherwise budget for PRIME at full freight. This is the single most important diligence item in the used-Ultherapy market.

Overview

US lift claim marketed for years (FDA status under verification — see our FDA guide); transducers consumable

How it works

The science

Microfocused ultrasound with visualization (MFU-V): the transducer images the tissue plane in real time (DeepSEE), then delivers focused thermal coagulation points at precise depths — 4.5mm (SMAS/platysma), 3.0mm (deep dermis), 1.5mm (superficial dermis) — triggering neocollagenesis and gradual lift over 2-6 months. Marketed with "lift" language for brow, submental, and neck, plus decollete wrinkle improvement (FDA status under verification — see our FDA guide). Results are line-count-dependent; skimped counts are the #1 cause of "Ultherapy didn't work" reviews.

Patented tech

DeepSEE is the real differentiator — transducer ultrasound imaging confirms coupling and target depth before firing, which no blind-delivery HIFU clone offers. "See what you treat" is load-bearing, not just branding.

Origin

Mesa, Arizona, USA (Ulthera, Inc., a Merz Aesthetics company).

FDA & regulatory status

FDA status under verificationRegulatory status under verification

FDA status under verification — see our FDA guide. We do not publish an indication or a clearance number for this profile until the record is confirmed against the FDA database.

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

What practices charge

$1,800-3,500 full face, $3,000-5,500 face+neck, $500-1,200 smaller zones; national averages near $2,700. Sold as a single annual treatment — each booking is a four-figure ticket.

Consumables & recurring cost

The whole economic story: DeepSEE transducers are line-limited (e.g., 2,400 lines) with expiration dates, ~$800-1,900 each depending on depth; a full face/neck uses multiple depths. Real provider cost ~$400-1,200 per treatment, sold only to registered accounts — counterfeit/"refilled" gray-market transducers are a documented industry problem Merz actively warns about. A 10-case/month practice can exceed $60k-100k/year in transducer spend.

Ideal for

Best-fit practice

Established medspas, derm, and plastics practices with consult-driven sales and clientele paying $2,500+ per session — 40-65, moderate laxity, surgery-averse, brand-aware. Wrong fit for discount-driven spas; the consumable load punishes low pricing.

Compliance

Medical director & delegation

Focused ultrasound typically delegated to RNs/NPs/PAs under physician oversight, with several states restricting further; because outcomes are so operator-dependent, Merz clinical training (which requires account standing) matters as much as the legal minimum.

Contraindications & screening

Open lesions or severe cystic acne in the area, implanted electrical devices, caution over metal implants/filler along planned lines, pregnancy, anticoagulation per protocol, and severe-laxity patients who need surgery.

Ownership

Warranty & service

PRIME consoles carry ~1-year Merz warranty; legacy consoles are increasingly end-of-life for parts as Merz pushes the PRIME upgrade cycle — get written confirmation of continued legacy support and transducer supply before buying used.

Resale & used market

Legacy consoles are plentiful and cheap precisely because of the transducer lockout — liquidity is high at $15k-45k but the buyer pool that can actually use them is small; values trend down as PRIME penetrates.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.